Merck says, research shows its Covid-19 pill works against variants
Laboratory studies show that Merck and Co's experimental oral Covid-19 antiviral drug, molnupiravir, is likely to be effective against known variants of the coronavirus, including the dominant, highly transmissible Delta, the company said.…